Pharmacogenomic Testing in Gilbert, AZ: How Your DNA Can Guide Mental Health Medication
Psychiatric medication selection has historically involved trial and error rather than biology, leaving many patients cycling through options that did not work or caused side effects before arriving at something that did (National Institutes of Health). Pharmacogenomic testing changes that by analyzing how a patient's genetic makeup affects the way their body processes medications, allowing providers to make more informed prescribing decisions from the start. At Core Self in Gilbert, we offer pharmacogenomic testing via cheek swab as part of our integrated psychiatric care.
What Pharmacogenomic Testing Is
Pharmacogenomics is the study of how genes affect an individual's response to medications. Each person metabolizes drugs differently based on variations in genes that code for liver enzymes responsible for breaking down and processing medications. These genetic variations can cause the same dose of the same medication to work well in one patient, produce side effects in another, and be largely ineffective in a third (National Institutes of Health).
In psychiatry, this matters particularly because the consequences of poor medication fit are significant. A patient who is a rapid metabolizer of a given antidepressant may clear the drug so quickly that it never reaches a therapeutic level in their system, leading their provider to assume the medication is simply not effective for them. A patient who metabolizes it too slowly may accumulate higher-than-intended concentrations and experience side effects that prompt discontinuation. Neither outcome has anything to do with the condition being treated. It has to do with biology.
Pharmacogenomic testing identifies where a patient falls on the spectrum for relevant metabolic pathways, giving prescribers specific information about which medications in a given class are more likely to be well-processed and which carry elevated risk of poor response or adverse effects.
How It Works at Core Self
Our pharmacogenomic testing is administered via cheek swab, a simple process that takes only minutes in our office. The swab is sent to a laboratory for analysis, and results are returned to your provider, who reviews them in the context of your full psychiatric history and current treatment needs.
The test does not make prescribing decisions automatically. The results are a tool that informs your provider's clinical judgment, not a replacement for it. Your provider reviews the findings with you, explains what they mean for your specific medication options, and uses them as one component of a broader evaluation that also includes your symptom history, prior medication responses, and current condition.
Pharmacogenomic testing is not a one-time diagnostic event. As your treatment evolves, the data can be referenced again when new medications are being considered. The genetic information does not change, so a single test has ongoing clinical utility over the full course of your care at Core Self.
Which Conditions It Applies To at Core Self
We apply pharmacogenomic testing to patients managing depression, anxiety, ADHD, bipolar disorder, and insomnia, all of which involve psychiatric medications where genetic variation in metabolism is clinically relevant.
For patients with depression, particularly those who have tried multiple antidepressants without consistent relief, pharmacogenomic testing can clarify whether prior medication failures were related to metabolic factors rather than the condition being treatment-resistant in a clinical sense (National Institutes of Health). This is a meaningful distinction. A patient who was told their depression is treatment-resistant may simply have been prescribed medications that their genetic profile was poorly suited to process.
For patients with ADHD, pharmacogenomic data helps guide stimulant and non-stimulant medication choices where metabolic variation affects efficacy and tolerability. For patients with bipolar disorder or insomnia where mood stabilizers or sleep medications are involved, the same principle applies.
Not every patient needs pharmacogenomic testing. Your provider will discuss whether it is relevant to your situation during the evaluation.
What the Results Actually Tell Your Provider
The results of a pharmacogenomic test categorize a patient's metabolism for relevant enzymes into ranges that indicate likely response. A medication may be flagged as likely to be metabolized at a normal rate, more rapidly than average, or more slowly than average. Some medications may be identified as having known gene-drug interactions that elevate the risk of a poor response in that patient.
This information does not eliminate all uncertainty in psychiatric prescribing. It does not tell your provider which medication will work, only which ones are more or less likely to be processed in a way that gives them a reasonable chance of working. Symptom history, diagnosis, prior response data, and clinical judgment all remain essential. The test adds a layer of biological information to that picture rather than replacing the rest of it.
For patients who have experienced unexpected side effects from medications in the past, or for whom standard doses have seemed unusually ineffective or unusually potent, pharmacogenomic testing often provides an explanation that reframes the prior treatment history in a clinically useful way.
To see how pharmacogenomic data fits into a broader picture of how psychiatric medications are selected and monitored, our post on how psychiatric medications work is a useful companion read.
Who Should Consider Pharmacogenomic Testing
Pharmacogenomic testing tends to be most valuable for patients who have tried multiple medications without finding an adequate response, patients who have experienced significant side effects from medications that are typically well-tolerated, patients who are beginning treatment and want to start with as much biological information as possible, and patients managing conditions where multiple medication classes are possible starting points.
If you fall into any of those categories, it is worth discussing with your provider at Core Self whether testing makes sense for your situation. The process is straightforward, the information is durable, and for patients where metabolic factors have been affecting treatment outcomes without anyone knowing it, the results can redirect care in a meaningful way.
Cost is a practical consideration. Coverage for pharmacogenomic testing varies by insurance plan. Our team will discuss coverage and any out-of-pocket cost with you before the test is ordered, so there are no financial surprises.
We encourage every patient to discuss their options openly with their provider before making any decisions about testing or treatment. Results vary by individual, and pharmacogenomic testing is one component of care, not a standalone solution. To speak with our team directly, contact us at (520) 346-0831 or book a free consultation online.
Frequently Asked Questions
Is pharmacogenomic testing the same as ancestry or consumer genetic testing?
No. Consumer genetic tests like ancestry or wellness kits analyze a different set of genetic markers for different purposes. Pharmacogenomic testing in a clinical setting focuses specifically on genes that affect how medications are metabolized, interpreted by a provider in the context of your psychiatric history and treatment. The two are not interchangeable, and consumer test results are not a substitute for clinical pharmacogenomic analysis.
How long does it take to get results?
Turnaround time varies by laboratory, but results are typically available within a few days to a couple of weeks. Your provider will follow up with you to review the findings once they are returned.
Will this test tell me which medication will definitely work?
No. Pharmacogenomic testing identifies how your body is likely to process certain medications, not which medication will definitively resolve your symptoms. It reduces the guesswork in prescribing by adding biological context, but clinical judgment, symptom history, and ongoing medication management remain essential to good psychiatric care.
Does insurance cover pharmacogenomic testing?
Coverage varies by plan. Some major insurers cover pharmacogenomic testing for psychiatric medication management, particularly for patients with documented histories of medication failure. Our team reviews your specific coverage before the test is ordered and will be transparent about what cost, if any, to expect.
Do I need to have tried and failed multiple medications to qualify for this test?
Not necessarily. While pharmacogenomic testing is particularly valuable for patients with a history of medication failures, it can also be useful at the start of treatment for patients who want to approach prescribing with as much information as possible from the beginning. Your provider will discuss whether testing is appropriate for your specific situation.
Key Takeaways
Pharmacogenomic testing analyzes how a patient's DNA affects the way their body metabolizes psychiatric medications, helping providers make more informed prescribing decisions.
At Core Self, the test is a cheek swab administered in-office. Results are reviewed by your provider in the context of your full psychiatric history, not interpreted in isolation.
Testing is available for patients managing depression, anxiety, ADHD, bipolar disorder, and insomnia — all conditions where genetic variation in drug metabolism is clinically relevant.
For patients who have experienced unexpected side effects or multiple medication failures, pharmacogenomic testing often provides biological context that reframes the treatment history.
Results vary by individual. Pharmacogenomic testing is one component of care at Core Self, not a replacement for comprehensive psychiatric evaluation.
Conclusion
If you have cycled through medications without finding a reliable fit, or if you want to start psychiatric care with as much information as possible, pharmacogenomic testing may be worth discussing at your next appointment. At Core Self in Gilbert, it is part of how we approach medication management as a whole-person practice. Call us at (520) 346-0831 or book a free consultation online to speak with a member of our team about whether testing makes sense for your situation.
References
National Institutes of Health. The Emergence, Implementation, and Future Growth of Pharmacogenomics in Psychiatry. https://pmc.ncbi.nlm.nih.gov/articles/PMC10755240/
National Institutes of Health. Pharmacogenomic Biomarkers and Their Applications in Psychiatry. https://pmc.ncbi.nlm.nih.gov/articles/PMC7760818/
National Institutes of Health. Selective Serotonin Reuptake Inhibitors and Adverse Effects: A Narrative Review. https://pmc.ncbi.nlm.nih.gov/articles/PMC8395812/
Medical Disclaimer: The information in this blog is for educational purposes only and does not constitute medical advice. Pharmacogenomic testing is available at Core Self as part of a comprehensive psychiatric evaluation and ongoing medication management. Individual results vary. Testing results should only be interpreted by a qualified psychiatric provider in the context of your full medical and mental health history. If you are experiencing a mental health crisis or thoughts of self-harm, please call or text 988 to reach the Suicide and Crisis Lifeline or go to your nearest emergency room. Core Self's services are available at our Gilbert and Chandler, Arizona locations and via telehealth throughout Arizona.
